Un Characterized Protein C6orf183: Potential Drug Target Or Biomarker

Target Name: Chromosome 6 open reading frame 183

NCBI ID: G389422

Chromosome 6 open reading frame 183

Other Name(s): Putative uncharacterized protein C6orf183 | C6orf183 | bA487F23.3

Un Characterized Protein C6orf183: Potential Drug Target Or Biomarker

Chromosome 6 open reading frame 183 (Putative uncharacterized protein C6orf183) is a gene that encodes a protein with a molecular weight of approximately 180 kDa. The protein is a member of the C6orf180-like family, which is characterized by the presence of a characteristic conserved domain that is similar to that of the protein C6orf180.

The C6orf180-like domain is composed of a nucleotide-rich region that is involved in the formation of a nucleosome, as well as a short alpha-helices that are involved in the protein's stability and localization. The protein is also known to contain a number of putative transmembrane domains, which suggest that it may be involved in cell signaling processes.

One of the most interesting aspects of C6orf183 is its potential as a drug target or biomarker. The C6orf180-like domain is known to be involved in a number of cellular processes, including the formation of the nucleosome, cell signaling, and inflammation. As such, it is possible that C6orf183 may be a useful target for drugs that are designed to modulate these processes.

For example, the C6orf180-like domain is known to be involved in the formation of the nucleosome, which is a complex structure that is composed of a series of DNA double-strands wrapped around a core of eight histone proteins. The nucleosome plays a crucial role in the regulation of DNA replication, and is thought to be involved in the development of cancer. As such, drugs that are able to alter the nucleosome composition or activity may be useful for treating a variety of diseases, including cancer.

Another potential application of C6orf183 as a drug target is its role in cell signaling. The C6orf180-like domain is known to be involved in the regulation of a variety of cellular processes, including cell signaling, cell adhesion, and inflammation. As such, drugs that are able to modulate these processes may be useful for treating a variety of diseases, including neurodegenerative disorders and inflammatory diseases.

In addition to its potential as a drug target, C6orf183 also has potential as a biomarker. The C6orf180-like domain is known to be expressed in a variety of tissues and cells, including brain, heart, and muscle. As such, it may be a useful biomarker for a variety of diseases, including neurodegenerative disorders, cancer, and inflammation.

Overall, C6orf183 is a gene that has a lot of potential as a drug target or biomarker. Its conserved domain and putative transmembrane domains suggest that it may be involved in a variety of cellular processes, including the formation of the nucleosome, cell signaling, and inflammation. Further research is needed to fully understand the function and potential of C6orf183 in these processes, and to determine its utility as a drug target or biomarker.

Protein Name: Chromosome 6 Open Reading Frame 183

The "Chromosome 6 open reading frame 183 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Chromosome 6 open reading frame 183 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets